Crossmark

A Quinoxaline Derivative as a New Therapeutic Agent for Sepsis through Suppression of TLR4 Signaling Pathways

Published Online: 2025-04-26

Authors

Hanieh, Hamza https://orcid.org/0000-0001-9230-3858
Alfwuaires, Manal A.
License Information

Text and Data Mining valid from 2025-04-26

Version of Record valid from 2025-04-26
More Information

Article History

Received: 27 December 2024

Revised: 3 March 2025

Accepted: 12 March 2025

First Online: 26 April 2025

Declarations

:

: The authors declare no competing interests.

Document is current